Literature DB >> 12473674

Protein phosphatase 2A regulates the stability of Pim protein kinases.

Julie A Losman1, X Peter Chen, Bao Q Vuong, Scott Fay, Paul B Rothman.   

Abstract

The pim family of proto-oncogenes encodes three serine-threonine kinases that have been implicated in the development of malignancies in mice and in humans. Expression of the Pim protein kinases is tightly regulated at the transcriptional, post-transcriptional, and translational levels. Dysregulation of pim transcription and pim mRNA stability have been implicated in Pim-mediated transformation. The data presented herein demonstrate that expression of the Pim kinases is additionally regulated at the post-translational level, by the serine-threonine phosphatase protein phosphatase 2A (PP2A). The catalytic subunit of PP2A associates with the Pim kinases in vivo, and the Pim kinases are substrates of PP2A phosphatase activity in vitro. Furthermore, overexpression of PP2A reduces the levels of the Pim proteins, whereas inhibition of PP2A activity by the protein phosphatase inhibitor okadaic acid stabilizes the Pim proteins. Finally, the effects of PP2A on the expression of the Pim proteins can affect Pim function. Taken together, these data suggest that PP2A activity is important for the regulation of the stability and function of the Pim kinases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473674     DOI: 10.1074/jbc.M208246200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

2.  Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A.

Authors:  Hongyun Li; Koji Okamoto; Melissa J Peart; Carol Prives
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

Review 3.  PIM kinase (and Akt) biology and signaling in tumors.

Authors:  Noel A Warfel; Andrew S Kraft
Journal:  Pharmacol Ther       Date:  2015-03-05       Impact factor: 12.310

Review 4.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

5.  Protein phosphatase 2A stabilizes human securin, whose phosphorylated forms are degraded via the SCF ubiquitin ligase.

Authors:  Ana M Gil-Bernabé; Francisco Romero; M Cristina Limón-Mortés; María Tortolero
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 6.  Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase.

Authors:  Sailay Siddiqi; Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-08

Review 7.  Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.

Authors:  Ying-Yi Li; Naofumi Mukaida
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

8.  Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation.

Authors:  Jian Chen; Masanobu Kobayashi; Stephanie Darmanin; Yi Qiao; Christopher Gully; Ruiying Zhao; Satoshi Kondo; Hua Wang; Huamin Wang; Sai-Ching Jim Yeung; Mong-Hong Lee
Journal:  Am J Pathol       Date:  2009-06-15       Impact factor: 4.307

9.  PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation.

Authors:  Mario Scarpa; Prerna Singh; Christopher M Bailey; Jonelle K Lee; Shivani Kapoor; Rena G Lapidus; Sandrine Niyongere; Jaya Sangodkar; Yin Wang; Danilo Perrotti; Goutham Narla; Maria R Baer
Journal:  Mol Cancer Ther       Date:  2021-02-10       Impact factor: 6.009

10.  Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.

Authors:  Jan Jacob Schuringa; Ki Young Chung; Giovanni Morrone; Malcolm A S Moore
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.